The FDA on Monday approved the Pfizer Covid-19 vaccine to be given to kids ages 12 to 15 on an emergency use basis. This is a significant step in expanding vaccination of school-age kids and will play an important role in fully opening America’s classrooms for next school year.
“Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic,” Acting FDA Commissioner Janet Woodcock, said in a statement. “Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our COVID-19 vaccine emergency use authorizations.”
“FDA has done everything we can to ensure that the Covid-19 vaccines we have authorized have met the agency’s high standards for quality, safety and effectiveness. We know that every time an American, including members of our own families, receives a Covid-19 vaccine dose, you are putting your trust in us,” Woodcock continued.
At the end of March Pfizer said that a clinical trial involving 2,260 12-to-15-year-olds showed the vaccine is 100% effective in preventing Covid-19.
According to CDC data, there were about 1.5 million COVID-19 cases reported in individuals aged 11 to 17 as of the end of April.
Like Newport Buzz? We depend on the generosity of readers like you who support us, to help with our mission to keep you informed and entertained with local, independent news and content. We truly appreciate your trust and support!